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Abstract 
Outpatient ambulatory electrocardiographic monitoring (AEM) is often used by 
practitioners to diagnose an arrhythmia. AEM devices can be mailed to the patient’s home or 
applied in the office setting. A common barrier that decreases the diagnostic utility is failure to 
successfully complete the monitoring. 
Objective: The purpose of this study is to compare the AEM completion rates between patients 
who self-apply the monitor at home and those who have the monitor applied in the office by 
clinical staff.  
Methods: A cross-sectional retrospective chart review was used. The electronic health records 
were reviewed for billable codes before and after April 2018 when a new office policy of mailing 
monitors to patients was implemented. A random sample of 50 patients was obtained from each 
timeframe. 
Results:  The sample included the electronic medical records of adult patients (n=100) seen in 
the Cardiology clinic. Over half 63 (63%) were female, and the majority 88 (88%) were 
Caucasian, with 10 (10%) Black or African American, and 1 (1%) reporting Asian race. The 
average age was 59 (range 20-100). Most patients 98 (98%) had health insurance. The office 
application group had a significantly higher rate of successful completion 62 (62%) compared to 
the mail group 38 (38%). The average number of days that the AEM was worn was 18 days 
(range 7-30 days).  
Conclusion: The results of this study indicate that professional support and application of AEM 
in the clinic setting may lead to an increase in completion rates.  
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Introduction 
Statement of the Problem 
Ambulatory Electrocardiographic Monitoring (AEM) assists in the diagnosis and 
management of patients with a known or suspected cardiac conduction disturbance or 
arrhythmia. The number of AEM’s being ordered for patients is on the rise (Kennedy, 2013). 
This is related to advances in technology and also the push to reduce costs by managing patient 
care outside of the hospital setting. 
In the cardiology clinic selected for this study, there were a large number of monitors that 
were cancelled, not worn properly, terminated early or not activated.  This resulted in a failure to 
obtain the rhythm monitoring data and the possibility of missing an important diagnosis.  This 
project was designed to address the following questions: 1) Was there a significant difference in 
completion rates between patients who had the AEM applied in the office compared to those 
who had the monitor mailed to their homes; and 2) Did in-office application improve completion 
rates. 
Common arrhythmias seen in clinical practice include premature atrial contractions 
(PAC’s), premature ventricular contractions (PVC’s), bradycardia, supraventricular tachycardia, 
atrioventricular (AV) block and ventricular tachycardia (VT).  Symptoms of cardiac conduction 
disturbances can sometimes be vague and may include reports of syncope, palpitations, chest 
pain, dyspnea or dizziness. It can be difficult to identify the cause of such symptoms in patients 
presenting with these complaints. 
Atrial fibrillation is the most common arrhythmia and is often seen in the elderly 
population and those with heart disease. The incidence and prevalence continues to rise, with 
some studies showing that by the year 2030 the number of people diagnosed with atrial 
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fibrillation will double to 12.1 million within the United States (Rosero et al., 2013). Atrial 
fibrillation can cause an irregular rapid heart rate and increases the risk of thrombotic events 
such as a stroke (NIH, 2018). The financial burden on the healthcare system related to treatment 
of atrial fibrillation is significant costing the United States about $6 billion dollars each year. 
Patients who are diagnosed with atrial fibrillation have almost $9000 more per year in health 
care costs than those who do not (CDC, 2018). In addition, syncope accounts for around one 
million emergency room visits per year in the United States with $2.5 billion per year spent on 
hospitalizations leading to extensive inpatient testing with low diagnostic yield (Patel & Quinn, 
2015). AEM’s have become a popular method for outpatient management of suspected 
conduction disturbances and are generally cost-effective when compared to inpatient hospital 
stays. The devices are becoming more advanced with longer monitoring time and the ability to 
store more data. Longer monitoring times increases the diagnostic yield significantly but this 
requires patient compliance and an understanding of how to use the device (Solomon et al., 
2016).   
The monitoring timeframe for AEM ranges anywhere from 24 hours to as long as 3 years 
or more. It can be used to monitor patients with a known arrhythmia to evaluate effectiveness of 
medications and interventions, such as whether to increase or decrease a beta blocker or initiate 
anticoagulation for stroke prevention prophylaxis. AEM is medically indicated in patients with 
symptoms of cryptogenic stroke to determine if asymptomatic atrial fibrillation is an underlying 
cause (Zimetbaum & Goldman, 2010).   
The AEM has the ability to be most useful when it is worn properly for the prescribed 
amount of time. Appropriate diagnosis and treatment of patients is more likely to be achieved 
among patients who complete the monitoring period successfully. 
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Definition of the Variables  
Ambulatory Electrocardiographic Monitor (AEM) refers to cardiac rhythm monitoring over an 
extended period of time in the outpatient setting. AEM’s were used in this project to describe the 
practice of recording the cardiac rhythm of a patient in an outpatient setting for a prescribed 
amount of time. 
Mobile Continuous Outpatient Telemetry (MCOT) is a cardiac rhythm monitoring device worn 
by a patient that continuously records for up to 30 days. The MCOT can be triggered by the 
patient when an event/symptom occurs, or automatically for certain rhythms (new onset atrial 
fibrillation, ventricular tachycardia and other serious arrhythmias). The ordering provider can 
then be notified of the event. 
Event Monitors are cardiac rhythm devices worn by a patients that only records when the patient 
triggers the monitor, or automatically when a serious arrhythmia is detected. 
Diagnostic Yield is defined as the number of significant diagnoses identified from cardiac 
monitoring. This is usually obtained once the AEM is completed when a final report is generated 
and sent to the ordering provider for interpretation and diagnosis.   
Mail Group in this project refers to the sample of patients who had monitors mailed to their 
home for self-application. 
Office Group refers to the sample of patients who had monitors applied by a healthcare 
professional at a scheduled office visit. 
Literature Review  
AEM is a valuable tool that has the potential to influence medical management by 
detecting arrhythmias. It can rule out an electrical conduction disturbance as a likely source of 
symptoms such as excessive fatigue, pre-syncope, syncope or palpitations. The American 
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College of Cardiology/American Heart Association (ACC/AHA) recommends the use of AEM 
to: assess symptoms that may be related to rhythm disturbances; assess risk of cardiac events in 
patients without symptoms; monitor the efficacy of antiarrhythmic medications; evaluate 
pacemaker and internal cardiac defibrillator function; and monitor for signs myocardial ischemia 
(ACC/AHA, 1999). The guidelines are used to classify which patients with or without symptoms 
may benefit from cardiac monitoring.   
AEM has become the most common technological tool ordered by health care providers 
to identify conduction disturbances (Kennedy, 2013; Zimetbaum & Goldman, 2010; Barrett et 
al., 2014; Smith, Riddell, Madon & Gleva, 2017; Solomon et al., 2016). There are several types 
of AEM devices, including 24 and 48-hour Holter monitors, looping and non-looping event 
monitors, real time mobile telemetry, and more recently, implanted loop recorders. With 
advances in technology these devices have become easier and more efficient to use. 
Holter monitors have long been considered ‘the gold standard’ using either three-lead or 
twelve-lead configuration. They are the least expensive of the AEM devices and usually covered 
by most insurance companies. The timeframe of 24-48 hours may not capture an arrhythmia that 
is occurring less frequently, therefore it is recommended that Holter monitoring is limited to 
those who are having frequent symptoms or have a high probability of an arrhythmia within a 
short timeframe (Ruwald & Zareba, 2013). Event monitors are worn 7-30 days and require that 
the patient is symptomatic, recognizes the symptoms, and is able to manage activation of the 
device correctly (Zimetbaum & Goldman, 2010). Mobile Cardiac Outpatient Telemetry (MCOT) 
provides continuous ‘real-time’ monitoring. The MCOT is either triggered by the patient or 
automatically based on a pre-determined algorithm decided by the ordering clinician (eg. 
sustained ventricular tachycardia, >6 second pauses, complete heart block, atrial fibrillation). 
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The information is wirelessly transmitted to a central hub and if the rhythm meets notification 
criteria the ordering clinician is notified (Ruwald & Zareba, 2013). This device captures the most 
data with minimal patient activation over a longer period of time and provides real time data. In 
this project, the only devices that were mailed to patients were the MCOT’s and event monitors.  
Holter monitors continued to be applied in the office. 
In reviewing the literature, no information was found specifically related to the method of 
AEM application and how it affects completion rates. However, there are studies comparing 
completion rates and factors such as type of monitor that is worn, appropriateness of order 
(Benditt et al., 2018), length of monitoring and ease of use (Barrett et al., 2014, Rosenberg et al., 
2012, Smith et al., 2017, Solomon et al., 2016), however these factors are beyond the scope of 
this paper to investigate.  
Several studies showed that patch monitors were easier to apply compared to Holters, 
which have electrodes and leads that need to be attached. Bansal and Joshi (2017) reviewed 
current AEM technology specifically looking at the ease of use and accuracy of patch monitors. 
The findings indicated that the use of a continuous single lead patch improved outcomes for all 
of the evaluated endpoints. Patient compliance was excellent with a median wear time of 13.6 
days (Reed et al., 2018). There have been several other studies comparing adhesive patch devices 
to other types of monitoring such as Holter, resting ECG and MCOT. The general outcomes 
from these preliminary studies show that the adhesive patch monitors are well tolerated, improve 
compliance, increase diagnostic yield and have higher ratings in patient satisfaction and ease of 
use compared to the traditional three or five lead Holter monitoring (Smith et al., 2017; Barrett et 
al., 2014; Rosenberg et al., 2012). 
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Within the biomedical research field there are studies that investigated factors known to 
influence ease of use and comfort with wearing a monitor or sensor. Results from these studies 
indicated that it was important for sensors to be simple to operate and not affect normal behavior 
or daily activities which improves length of monitoring and completion rates (Bergmann & 
McGregor, 2011; Bergman, Chandaria & McGregor, 2012). 
 
Theoretical Framework 
The theoretical framework that will be used to help guide this project is Donabedian’s 
Model for measuring the quality of care. In 1966 Donabedian’s ground-breaking article 
“Evaluating the Quality of Medical Care” was published in the Millbank Memorial Fund 
Quarterly where he provided a framework that can be used to assess healthcare quality. 
The model has three integral parts; structure, process, and outcome. The structure is the 
environment in which the health care delivery is applied such as the type of facility (clinic, 
hospital) or the type of electronic health record (EHR) that is used. The process measures are the 
actual actions of the health care workers within the structure. Some examples of process 
measurements are the length of time a provider spends with the patient or the thoroughness of 
instructions for outpatient monitoring. Outcomes, such as AEM completion rates are the 
quantifiable measurements that can be used to evaluate the impact of the healthcare delivery 
(AHRQ, 2018). 
The Donabedian model organizes the components of this project. The office structure 
includes personnel and staffing, patient flow and average daily census. The process of how 
AEM’s are ordered and managed is key to this project. This includes determining how and where 
 
9 
 
the AEM is applied, origination and follow up of the AEM order, and insurance prior 
authorization. The outcome measurement is AEM completion. 
Methodology and Design 
Assumptions 
1) Patients who receive cardiac monitors are able to read and comprehend the directions 
2) The AEM ordered was the appropriate type of monitor based on symptoms and diagnosis. 
3) All patients within the practice who wore and AEM were entered into the EHR billing 
database. 
4) Patients in the project received either an event monitor or an MCOT that functioned properly. 
Design and Setting 
The project took place in a busy cardiology practice located in a suburb of a Midwestern 
metropolitan city. The practice had experienced rapid growth over the past 3three years with the 
most recent report of an annual growth of 27% since the prior year (S.S, Director of Cardiology 
Practice Operations, personal communication, July 8th, 2018). Five new cardiologists and two 
nurse practitioners joined the practice since moving into a new office space in 2016. The 
majority of patients seen were insured with many of them on Medicare or Medicare replacement 
plans. The clinic had on average of 4-5 four to five providers seeing 75-100 patients daily with 
over 9000 patients checked in for visits during the first quarter of 2018. One of the many services 
that the cardiology department offered was the reading and interpretation of cardiac testing 
including AEM reports. 
Orders for AEM devices were generated from inpatient hospital stays, emergency 
department visits and outpatient clinic visits. The order was then sent to a prior authorization 
specialist who is responsible for verifying insurance coverage and obtaining authorization if 
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indicated. Once the insurance authorization had been obtained, the order was sent to the AEM 
company and indicated whether it was to be mailed to the patient or placed in the office. It was 
left to the discretion of the physician group whether it was preferred to mail monitors or stock an 
office supply to allow application in the clinic. 
It was the responsibility of the Pacemaker Clinic staff to monitor the patients who are on 
the AEM service. This department was staffed by four registered nurses, two of whom were full-
time and two who work part-time. If a recorded rhythm met the urgent criteria, which was 
decided by the cardiologists, the AEM company notified the office or on-call provider after 
hours. The pacemaker nurses triage the incoming calls and monitoring data. Upon AEM 
completion, a final report was generated in the EHR. The pacemaker RN forwarded the report to 
the ordering provider for interpretation and further recommendations. 
The growth and expansion of the cardiology department had been recognized and 
celebrated, but with it came many challenges. The healthcare leaders and administrators had to 
reassign duties and workflow to meet the demands of the increased patient volume and 
workload. Due to staffing shortages and lack of patient room availability, it was decided shortly 
before April 2018 that heart monitors would be mailed to the patients’ home rather than having a 
scheduled appointment for application of the monitor in the office by a medical assistant (MA). 
There were many patients who did not wear the monitor, then came to their 30-day follow-up 
without the necessary data available to review. It was not uncommon for the patient to stop 
wearing the monitor, fail to transmit data, fail to keep a diary of symptoms which may be related 
to a lack of understanding of the purpose of the AEM and how to operate the device. 
Population Sample and Selection Process 
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A cross-sectional retrospective chart review was used for this quality improvement 
project to answer the proposed research questions. The population sample for this project was 
randomly selected from a chart review of the billable codes for AEM devices that were entered 
into the EHR. The codes were obtained from August 1, 2017 to October 31, 2017 and then from 
August 1, 2018 to October 31, 2018. These timeframes were selected for data collection before 
and after the implementation of mailing monitors to the patient’s residence. The average number 
of AEM orders processed per month was around 150. A random sample of fifty patients from 
each of the two time points was selected. This provided a total sample size of 100.  Exclusion 
criteria included anyone younger than 18 years of age and patients with implanted loop recorders 
or Holter monitors. Holter monitors were not included in the study because they were applied in 
the office. This project did not include human research therefore the IRB designated it as exempt 
with approval to proceed with the project. Approval was also obtained from the management 
within the clinic.   
Data Collection Protocol 
Data on the population sample was collected from the available billing and coding reports 
generated from AEM orders and the office EHR. This included the patient demographics, 
diagnosis/ICD codes, CPT codes for the type of monitor ordered, insurance information, length 
of monitoring period, days that monitor was worn, successful completion, and order source. Also 
included in the data collected was whether the monitor was mailed to the patient or placed in the 
office. Daily reports from the EHR, in addition to the billing and coding reports showed 
monitoring of patient wear times and cancellations. No sensitive patient identifiers were recorded 
such as date of birth, social security numbers or addresses. The AEM data was entered into 
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Research Electronic Data Capture (REDcap), a secure web application designed for building 
surveys for data collection and creating a database that resided on a secure server.   
Data Analysis 
Data was transferred from REDcap to IBM SPSS 25 (IBM Corp, Armonk, NY, 20113).  
Descriptive statistics were used to analyze the data results and patient characteristics. A Chi 
Square test was used to assess the differences in completion rates between the mail group and 
office group. 
Table 1 
______________________________________________________________________________ 
Sample Characteristics.      n=100 
Age Mean                            59 years (range 20-100) 
Male                                     37 (37%) 
Female                                 63 (63%) 
Caucasian                            88 (88%) 
African American               10 (10%) 
Asian                                   1 (1%) 
Hispanic                              3 (3%) 
Other/Not Reported.           1 (1%) 
Health Insurance                98 (98%) 
 
Results 
The study sample consisted of 100 patients, 50 of whom had the AEM mailed to their 
home and 50 who had the monitor applied in the office (see Table 1). The average age was 59 
 
13 
 
years (range 20-100). Most of the patients were female  63 (63%), white  88 (88%), and had 
insurance coverage  98 (98%). There were two types of monitors used in this study, mobile 
outpatient telemetry 42 (42%), and event monitors 58 (58%). The ordered length of time was, on 
average, 18 days (range 7-30 days).  
Out of the total sample (n=100), 62 (62%) successfully completed monitoring for the 
prescribed amount of time and 38 (32%) failed to complete monitoring, as shown in Table 2. The 
highest rate of non-completion was within the mail group 26 (26%) compared to the office group 
12 (12%). Three patients did not wear the monitor for any of the prescribed days. A contingency 
table was created using the observed number of completions and non-completions between the 
two groups. A Chi Square test showed a significant difference between the mail group and office 
group supporting a correlation between how the monitors are applied and completion rates (see 
Table 2). 
 
Table 2 
___________________________________________________________________ 
Comparison of Completion Rates Between Mail Group and Office Group 
 
  AEM Completion     
  
 
 
Completed 
 
 
 
Not Completed 
 
 
 
Total Application Method 
Office 38 (38%) 12 (12%) 50 (50%) 
Mail 24 (24%) 26 (26%) 50 (50%) 
Total 62 (62%) 38 (38%) 100 (100%) 
X2 = 8.319, df = 1, p = .005 
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Most of the orders 72 (72%) originated from the office and the rest of the orders 28 
(28%) were generated from ER visits or inpatient stays. The electronic medical records revealed 
that seven patients required intervention, including two atrial fibrillation ablations, two loop 
recorder implants, two pacemaker implants and one internal cardiac defibrillator. The most 
frequent diagnosis used when ordering the AEM was palpitations 43 (43%) (see Table 3).   
Table 3 
______________________________________________________________________________ 
ICD 10/Diagnosis Codes Frequency for AEM Orders 
______________________________________________________________________________                                            
 Diagnosis                                 ICD 10 Code                                  Frequency (%) 
______________________________________________________________________________ 
Palpitations                                     R00.2                                          43 (43%) 
Syncope/Collapse                           R55                                           17 (17%) 
Bradycardia                                    R00.1                                            5 (5%) 
Transient Ischemic Attack             G45.9                                            3 (3%) 
Atrial Fibrillation                           I48                                            18 (18%) 
Supraventricular Tachycardia        I47.1                                             3 (3%) 
Dizziness/Giddiness                       R42                                               6 (6%) 
Ventricular Tachycardia                 I47.2                                             2 (2%) 
Cerebrovascular Infarction             I63.9                                             2 (2%) 
Atrioventricular Block                    I44                                                1 (1%) 
Other Conduction Disorder             I45.9                                             1(1%) 
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Discussion 
 This retrospective chart review found that patients with monitors applied in the office 
had a significantly higher rate of completion compared to those who had the AEM mailed to 
their home. A variety of reasons could explain these findings. Patients may feel more 
comfortable with the device when they receive instructions face to face in the clinic setting and 
have the opportunity for their questions and concerns to be answered along with support as well 
as proper initiation by trained personnel.  The office staff can clearly explain the importance of 
the AEM as a tool that assists providers in making important healthcare decisions.   
Patients who have an AEM ordered after a hospital stay receive a large amount of 
education and sometimes a new diagnosis.  Having an AEM arrive by mail could be confusing 
for some patients especially when it was prior to the follow-up appointment after hospital 
discharge.  Wearing an AEM requires active participation of the patient. Encouraging and 
supporting patients who are wearing these monitors by providing instruction by medically 
trained staff is an intervention that could be implemented in the outpatient clinic setting to 
increase completion rates. 
The longer the monitor is worn and operating correctly, the more rhythm data is 
generated.  This leads to greater confidence in clinical decision making.  The AEM reports are 
often used to help determine medication management or rule out an arrhythmia.  A report 
showing 100% sinus rhythm for 30 days provides greater confidence in ruling out a conduction 
disturbance compared to a report showing 100% sinus rhythm for a patient who only wore the 
monitor for 3 days.  It is especially useful for the symptomatic patient to record events so that it 
can be correlated with the rhythm at that time.   
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An interesting finding in this project was the high number of female patients 63 (63%) 
compared to males who had an AEM ordered. The most frequent ICD 10 diagnosis code overall 
was palpitations (43%) and the second most frequent reported ICD 10 diagnosis code was 
syncope (16%).  Palpitations and syncope are symptoms associated with disorders common in 
females such as thyroid disease, menopause, or depression and anxiety.  It is also known that 
women are more likely than men to present with atypical symptoms (abdominal pain, dyspnea, 
extreme fatigue, syncope) in acute coronary syndrome (Mehta et. al., 2016).  Whether there is a 
correlation between the high rate of AEM’s ordered in this patient population and these reported 
symptoms was not established in this project but could be and area of interest for future studies. 
Currently the clinic continues to mail the monitors to the patient’s home.  Presenting the 
results of this study to health care administrators within the organization would support a 
decision to re-implement the policy of placing the AEM on patients in the clinic.  A cost benefit 
analysis may show potential financial gains looking at the number of tests, procedures, 
interventions and new patient consults generated by AEM completion. 
In summary, AEM is an important tool used to manage, treat and diagnose patients who 
may have underlying cardiac conduction disturbances.  The popularity of outpatient monitoring 
technology continues to expand providing extensive rhythm data, with more responsibility 
placed on the patient to ensure success of the intervention.  Further research is needed to explore 
interventions that increase AEM completion with the potential to significantly improve the care 
and management of patients suspected of having a conduction disturbance.  
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